Dissection of GvHD and GvL by FBTA05, a novel trifunctional anti-CD3 x anti-CD20 antibody

被引：0
|
作者：
Buhmann, R. [1 ]
Stanglmaier, M. [2 ]
Simoes, B. [3 ]
Menzel, H. [4 ]
Peschel, C. [4 ]
Ruf, P. [2 ]
Lindhofer, H. [2 ]
Kolb, H. -J. [3 ]
机构：
[1] LMU, Klinikum Grosshadern, Munich, Germany
[2] TRION Res, Munich, Germany
[3] Helmholtz Zentrum, Munich, Germany
[4] TU, Klinikum Rechts Isar, Munich, Germany
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [41] First Surgical Experience of Intraperitoneal Treatment with the Trifunctional Antibody Catumaxomab (Anti-EpCam x Anti-CD3) for Epithelial Ovarian Cancer
    Papanikolaou, Georgios
    Fotopoulou, Christina
    Braicu, Ioana
    Chekerov, Radoslav
    Schmidt, Sven Christian
    Pietzner, Klaus
    Sehouli, Jalid
    ANTICANCER RESEARCH, 2011, 31 (08) : 2603 - 2608
  • [42] Adoptive immunotherapy of recurrent B-cell malignancies after allogeneic stem cell transplantation with Bi20 (FBTA05) a CD3xCD20 trifunctional antibody and donor lymphocyte transfusion
    Buhmann, R.
    Simoes, B.
    Stanglmaier, M.
    Yang, T.
    Faltin, M.
    Bund, D.
    Lindhofer, H.
    Kolb, H. -J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S45 - S45
  • [43] TRANSLATIONAL FINDINGS FOR REGN1979, A HUMAN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY: FROM PRECLINICAL TO FIRST-IN-HUMAN STUDY IN PATIENTS WITH CD20+B-CELL MALIGNANCIES.
    Zhu, M.
    Smith, E.
    Kirshner, J.
    Toroghi, M.
    Davis, J.
    Di-Cioccio, A.
    Retter, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S103 - S103
  • [44] Donor CD8+ T-Cells mediate GVL without GVHD in recipients conditioned with anti-CD3 mAB.
    Zhang, Chunyan
    Lou, Jingwei
    Todorov, Ivan
    Li, Nainong
    Lin, Chia-Lei
    Cao, Yuan
    Contag, Christopher
    Kandeel, Fouard
    Forman, Stephen
    Zeng, Defu
    CLINICAL IMMUNOLOGY, 2006, 119 : S36 - S36
  • [45] Donor CD8+ T cells facilitate engraftment and mediate GVL without GVHD in recipients conditioned with anti-CD3 MAB
    Zhang, C
    Lou, J
    Huang, T
    Todorov, I
    Cao, Y
    Contag, C
    Kandeel, F
    Forman, S
    Zeng, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 51 - 51
  • [46] Obinutuzumab: a new class of anti-CD20 monoclonal antibody
    Gagez, Anne-Laure
    Cartron, Guillaume
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (05) : 484 - 491
  • [47] Anti-CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis
    Korhonen, Riku
    Moilanen, Eeva
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106 (01) : 13 - 21
  • [48] What signals are generated by anti-CD20 antibody therapy?
    Bonavida B.
    Current Hematologic Malignancy Reports, 2006, 1 (4) : 205 - 213
  • [49] A Novel Anti-B7-H3 x Anti-CD3 Bispecific Antibody with Potent Antitumor Activity
    Feng, Yan
    Xie, Kun
    Yin, Yanxin
    Li, Bingyu
    Pi, Chenyu
    Xu, Xiaoqing
    Huang, Tao
    Zhang, Jingming
    Wang, Bo
    Gu, Hua
    Fang, Jianmin
    LIFE-BASEL, 2022, 12 (02):
  • [50] Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus
    Arin, MJ
    Engert, A
    Krieg, T
    Hunzelmann, N
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) : 620 - 625
12345